POTS IS NOT THE SAME FOR EVERYONE
POTS IS NOT THE SAME FOR EVERYONE
POTS describes a pattern of excessive heart-rate increase and symptoms when upright, but it does not explain why those symptoms are occurring. Some people show signs of impaired peripheral nerve function or blood pooling. Others have low circulating blood volume, excessive sympathetic activation, an autoimmune association, or another condition contributing to their autonomic dysfunction.
These patterns are often called POTS phenotypes. They are not rigid categories, and many patients have findings associated with more than one phenotype. Recognizing the dominant and contributing patterns can help clinicians select appropriate testing, identify conditions that may require further evaluation, and develop a more individualized recovery plan.
This page is provided for educational purposes only. It cannot determine which POTS phenotype you have and should not be used to diagnose yourself or select treatment without appropriate clinical evaluation. POTS symptoms and phenotypes frequently overlap, and similar symptoms can occur with other medical conditions.
A POTS Diagnosis Is the Beginning, Not the Full Explanation
POTS is diagnosed by the body’s abnormal heart-rate response to standing when that response is accompanied by symptoms of orthostatic intolerance. The diagnosis confirms what happens when you are upright, but it does not necessarily explain why it happens.
Two people can meet the same diagnostic criteria for POTS and have very different symptoms, clinical findings, contributing conditions, and paths to recovery. One person may have difficulty constricting blood vessels in the legs. Another may have reduced circulating blood volume. Someone else may show excessive sympathetic activation, an autoimmune association, or autonomic dysfunction secondary to another illness or injury.
This is why identifying the clinical pattern behind the diagnosis matters. A thoughtful evaluation looks beyond the change in heart rate to examine blood pressure, circulation, neurologic findings, symptom triggers, medical history, laboratory results, and associated conditions.
The important question is not only, “Do I have POTS?” It is also, “What may be driving my POTS?”
How the POTS Patterns Fit Together
Three physiologic phenotypes may overlap within one patient.
Neuropathic
Impaired small-fiber autonomic control may reduce peripheral vasoconstriction and increase blood pooling.
Hyperadrenergic
Excessive sympathetic activation may be primary or may compensate for another circulatory problem.
Hypovolemic
Reduced circulating blood volume may limit venous return and increase the heart-rate response to standing.
One patient may express all three patterns
Secondary POTS describes where the disorder developed
It is an etiologic category, not a fourth equivalent physiologic phenotype.
This graphic shows neuropathic, hyperadrenergic, and hypovolemic POTS as three potentially overlapping physiologic patterns. Secondary POTS identifies the illness, injury, or condition associated with their development.
Five Clinical Patterns Commonly Seen in POTS
POTS is often discussed in terms of several clinical phenotypes. A phenotype is a recognizable pattern of symptoms, examination findings, test results, and contributing mechanisms. It is not a separate disease and does not replace the diagnosis of POTS.
The five patterns most useful for understanding an individual patient are:
Neuropathic or small-fiber POTS
Reduced nerve control of blood vessels may allow excessive blood pooling, particularly in the legs and abdomen.Hyperadrenergic POTS
Excessive sympathetic nervous system activation may contribute to marked tachycardia, tremulousness, sweating, anxiety-like physical symptoms, and sometimes an increase in blood pressure while standing.Hypovolemic or low-volume POTS
Reduced circulating blood volume may limit the amount of blood returning to the heart when upright.Autoimmune-associated POTS
POTS may develop alongside an autoimmune disorder or after an immune-triggering event. This association does not mean that every case of POTS is autoimmune.Secondary POTS
The autonomic dysfunction occurs in association with another identifiable condition, illness, injury, medication effect, or physiologic stressor.
Most Patients Do Not Fit Neatly Into One Box
These patterns frequently overlap. A patient may have low blood volume and impaired peripheral vasoconstriction while also showing increased sympathetic activation. In other cases, a secondary condition may initiate autonomic dysfunction that later produces features of several phenotypes.
The goal is not to force every patient into a single category. The goal is to identify the dominant pattern, important contributing factors, and findings that may change the evaluation or recovery plan.
Hyperadrenergic POTS
Hyperadrenergic POTS is characterized by excessive activation of the sympathetic nervous system, particularly while upright. The sympathetic nervous system is responsible for the body’s “fight-or-flight” response and helps regulate heart rate, blood pressure, sweating, and circulation.
When this response becomes excessive, standing may produce much more than an increased heart rate. Patients may experience a powerful internal surge that can feel like panic even when they are not emotionally anxious.
Findings That May Suggest This Pattern
Marked heart-rate increase when standing
An increase in blood pressure while upright
Trembling, internal vibration, or shakiness
Forceful heartbeat or palpitations
Excessive or unusual sweating
Flushing
Headache or migraine
Chest discomfort
Heightened sensitivity to noise, light, pain, or stimulation
Difficulty sleeping or feeling persistently “wired”
Episodes triggered by standing, exertion, heat, meals, stress, or sensory overload
These symptoms are physiologic and should not automatically be dismissed as anxiety. However, anxiety and hyperadrenergic POTS can coexist and may intensify one another.
How It May Be Evaluated
Evaluation may include:
Supine and standing heart rate and blood pressure
The blood-pressure pattern during an active stand or tilt-table test
Supine and upright plasma norepinephrine testing when clinically appropriate
Review of medications and stimulants that may increase sympathetic activity
Assessment for conditions that can produce similar symptoms
An upright norepinephrine level of 600 pg/mL or higher is commonly used as supportive evidence of a hyperadrenergic pattern. It does not, by itself, prove that excessive sympathetic activation is the primary cause of the patient’s POTS.
An Important Distinction
The body may increase sympathetic activity because it is trying to compensate for low blood volume, blood pooling, or impaired blood-vessel constriction. A patient can therefore have elevated norepinephrine and hyperadrenergic symptoms without having a purely primary hyperadrenergic form of POTS.
A strong sympathetic response may be the primary problem, or it may be the body’s attempt to compensate for another circulatory problem.
Hypovolemic or Low-Volume POTS
Hypovolemic POTS is associated with an abnormally low volume of blood circulating through the body. Many patients with POTS have some degree of reduced plasma or total blood volume, although the severity and underlying cause can vary.
When blood volume is low, less blood returns to the heart after standing. The heart rate may increase to help maintain cardiac output and blood flow to the brain and other organs.
Low-volume POTS is more complex than simply “not drinking enough water.” Some patients appear to have difficulty retaining sodium and fluid or regulating the hormones responsible for maintaining blood volume.
Findings That May Suggest This Pattern
Symptoms that are worse in the morning
Lightheadedness, weakness, or near-fainting while upright
Exercise intolerance
Fatigue and cognitive slowing
Symptoms aggravated by heat, sweating, illness, vomiting, diarrhea, menstruation, or inadequate fluid intake
Low or low-normal blood pressure
Improvement with appropriate fluid, sodium, compression, or recumbent positioning
Frequent thirst or salt craving in some patients
Reduced tolerance for prolonged standing
Improvement after consuming fluid or sodium may support a low-volume contribution, but it does not establish the phenotype by itself. Many forms of POTS temporarily improve when circulating volume is expanded.
How It May Be Evaluated
Evaluation may include:
Supine and standing heart rate and blood pressure
Review of daily fluid, sodium, nutrition, and urine patterns
Laboratory testing for anemia, electrolyte abnormalities, kidney function, and other potential contributors
Assessment for blood loss, gastrointestinal losses, endocrine disorders, medication effects, or inadequate intake
Plasma renin and aldosterone testing in selected patients
Direct blood-volume measurement when clinically appropriate and available
Renin and aldosterone findings in POTS can be inconsistent and must be interpreted in context. Normal laboratory results do not necessarily exclude a meaningful low-volume component.
Hydration Is Not One-Size-Fits-All
Increasing fluid and sodium may help many patients with low-volume POTS, but more is not automatically better. Individual recommendations should account for blood pressure, kidney and heart function, medications, laboratory findings, diet, and the patient’s response.
Low blood volume may contribute to POTS even when a patient drinks plenty of water. The problem may involve how the body retains and distributes that fluid.
Secondary POTS: When Another Condition Contributes
Secondary POTS describes postural tachycardia and orthostatic symptoms that develop in association with another identifiable illness, injury, or medical condition.
Unlike neuropathic, hyperadrenergic, and hypovolemic POTS, secondary POTS is not a single physiologic phenotype. It describes the clinical context in which POTS developed. A patient with secondary POTS may still demonstrate one or more of the three major physiologic patterns.
Conditions and Events Associated With Secondary POTS
Concussion and Traumatic Brain Injury
POTS or other forms of autonomic dysfunction may develop after a concussion or more significant traumatic brain injury. These patients may also experience exercise intolerance, headache, dizziness, cognitive fatigue, sleep disturbance, visual dysfunction, and sensitivity to light or noise.
Postconcussion POTS is classified as secondary POTS. It should not be labeled neuropathic POTS unless there is separate evidence of peripheral autonomic or small-fiber neuropathy.
Postinfectious Illness and Long COVID
Some patients develop POTS after a viral or bacterial illness. Post-COVID autonomic dysfunction has brought increased attention to this pattern, although POTS was recognized following infections long before the COVID-19 pandemic.
The mechanisms may include immune activation, altered vascular regulation, reduced blood volume, autonomic nerve dysfunction, prolonged inactivity, or a combination of factors.
Autoimmune-Associated POTS
POTS may occur in patients with autoimmune diseases or following an apparent immune trigger. Reported associations include Sjögren syndrome, systemic lupus erythematosus, autoimmune thyroid disease, and other immune-mediated disorders.
Research continues to examine autoantibodies and immune mechanisms in POTS. At present, an autoimmune disorder or a positive antibody test does not automatically establish that autoimmunity caused the patient’s POTS.
Small-Fiber and Systemic Neuropathies
Diabetes, autoimmune disease, certain infections, toxic exposures, nutritional disorders, and other conditions can damage small autonomic nerve fibers. When an identifiable disorder causes the neuropathy, the patient may reasonably be described as having both secondary and neuropathic POTS.
Connective-Tissue and Hypermobility Disorders
POTS is frequently seen in patients with generalized joint hypermobility and hypermobile Ehlers-Danlos syndrome. The relationship is clinically important, but the exact mechanisms and degree of causation remain under investigation.
Other Potential Contributors
POTS may also occur in association with:
Surgery or significant physical trauma
Pregnancy or the postpartum period
Prolonged illness or extended inactivity
Neurologic disorders
Endocrine or metabolic disorders
Medication or substance effects
Other systemic medical conditions
Associated Condition Does Not Always Mean Proven Cause
Finding an illness, injury, or condition that occurred before POTS does not prove that it caused the autonomic dysfunction. The timing, biologic plausibility, objective findings, competing explanations, and overall clinical pattern must be considered together.
Some disorders can also mimic POTS rather than cause it. Significant dehydration, anemia, uncontrolled thyroid disease, active infection, blood loss, and medication effects should be evaluated before persistent orthostatic tachycardia is attributed to POTS.
Secondary POTS identifies the setting in which the disorder developed. The patient’s physiologic phenotype helps explain how the autonomic dysfunction is being expressed.
Can I Have More Than One Type of POTS?
Yes. Mixed presentations are common because the major POTS phenotypes describe interacting physiologic mechanisms rather than completely separate diseases.
For example, impaired small-fiber nerve function may reduce blood-vessel constriction and allow blood to pool in the lower body. This can reduce the amount of blood returning to the heart and contribute to a low-volume state. The sympathetic nervous system may then increase its activity to preserve blood pressure and circulation.
That one patient could demonstrate features of:
Neuropathic POTS
Hypovolemic POTS
Secondary hyperadrenergic activation
A patient with secondary POTS following a concussion, infection, or autoimmune illness may develop a similar combination of physiologic patterns.
The Dominant Pattern May Change
A patient’s presentation may also change during recovery. Low blood volume may be more prominent early in the illness, while exercise intolerance, sympathetic overactivation, impaired vascular control, or postexertional symptom worsening may become more apparent later.
Treatment, medication, physical conditioning, sleep, nutrition, hormonal changes, illness, heat exposure, and stress can also change the findings observed during testing.
For this reason, identifying a POTS phenotype is not a one-time act of assigning a permanent label. It is an ongoing clinical process of determining which mechanisms appear most important at the patient’s current stage of illness and recovery.
You may have one dominant POTS phenotype, several overlapping patterns, and a separate condition that contributed to their development.
How Is a POTS Phenotype Identified?
There is no single blood test, scan, or standing test that can identify a patient’s POTS phenotype. The most reliable approach is to combine the clinical history with orthostatic testing, physical examination, laboratory findings, and the patient’s response to specific physiologic challenges.
1. Understand the Timeline
The evaluation should first determine when the symptoms began and what was happening at the time. Important questions include:
Did symptoms begin after a concussion, infection, surgery, pregnancy, or major illness?
Is there a history of autoimmune disease, diabetes, hypermobility, neuropathy, or another systemic disorder?
Which symptoms appeared first?
Have the symptoms remained stable, progressively worsened, or changed over time?
What factors trigger a flare, and what reliably improves it?
The timeline may help identify a secondary cause or contributing condition, but timing alone does not prove causation.
2. Measure the Response to Standing
An active stand test, NASA Lean Test, or tilt-table test can document changes in:
Heart rate
Blood pressure
Symptoms
Blood pooling
Tolerance for remaining upright
The timing and progression of the response
The heart-rate increase helps determine whether the diagnostic criteria for POTS are met. The accompanying blood-pressure and symptom patterns may provide additional clues about the underlying physiology.
3. Look Beyond Heart Rate
Heart rate is only one part of autonomic function. A broader examination may assess:
Peripheral circulation and dependent blood pooling
Sweating and temperature regulation
Sensory findings that may suggest small-fiber dysfunction
Joint hypermobility
Neurologic and vestibular function
Breathing patterns
Exercise tolerance and recovery
Cognitive, visual, sleep, and gastrointestinal symptoms
4. Use Laboratory and Specialized Testing Selectively
Testing should be guided by the history and examination rather than ordering every available study for every patient. Depending on the clinical findings, further evaluation may include:
Blood counts, electrolytes, iron studies, thyroid testing, and other screening laboratories
Supine and upright plasma catecholamines
Renin and aldosterone testing
Autonomic reflex or sudomotor testing
Skin biopsy for small-fiber neuropathy
Cardiac testing
Evaluation for autoimmune, endocrine, neurologic, or systemic disease
5. Reassess the Pattern Over Time
The dominant physiology may become clearer as treatment progresses. Changes in orthostatic response, exercise tolerance, symptom triggers, and recovery can provide clinically useful information that was not apparent during the initial evaluation.
Why Does the POTS Phenotype Matter?
The diagnosis of POTS confirms a pattern of orthostatic tachycardia and symptoms. Identifying the dominant physiologic pattern may help explain why those symptoms are occurring and which parts of the recovery plan deserve the greatest attention.
It does not create a simple formula in which one phenotype always receives one treatment. It helps clinicians make more informed decisions and monitor whether the patient is responding as expected.
Volume and Circulatory Support
When low circulating volume appears to be important, the plan may place greater emphasis on individualized fluid and sodium intake, nutrition, compression, medication review, and investigation of conditions that interfere with fluid retention.
These recommendations must account for blood pressure, kidney and heart function, medications, laboratory findings, and other medical conditions.
Blood Pooling and Vascular Control
When impaired peripheral vasoconstriction or blood pooling is prominent, compression, positional strategies, lower-body muscle activation, and carefully selected rehabilitation may become particularly important.
Evidence of small-fiber dysfunction may also justify further investigation into the cause of the neuropathy.
Sympathetic Overactivation
When excessive sympathetic activity is prominent, clinicians may consider the patient’s blood-pressure response, sleep, sensory load, breathing pattern, medication effects, stimulants, pain, and physiologic triggers.
The first task is determining whether the sympathetic response appears to be the primary problem or compensation for low volume, blood pooling, or another circulatory limitation.
The Underlying Condition
In secondary POTS, the associated illness or injury may substantially influence the recovery plan. A patient who develops POTS after concussion may require concurrent management of visual, vestibular, cognitive, cervical, sleep, and exercise-related dysfunction.
A patient with postinfectious or autoimmune-associated POTS may require a different medical evaluation and a different expected recovery timeline.
Exercise and Autonomic Rehabilitation
Exercise is commonly recommended for POTS, but the starting position, intensity, progression, symptom limits, and recovery time should reflect the individual patient’s physiology and current capacity.
A program that progresses too quickly can provoke a prolonged flare. A program that remains too limited may fail to provide the stimulus needed for adaptation. Effective rehabilitation requires repeated measurement and adjustment rather than a generic exercise handout.
Exercise intolerance is common in POTS, but a delayed and prolonged post-exertional crash may represent a different pattern. Learn the difference between exercise intolerance and post-exertional malaise.
The phenotype does not determine the entire treatment plan. It helps identify which physiologic problems should be addressed, monitored, and reassessed.
Can I Identify My POTS Phenotype Myself?
Symptoms can provide useful clues, but they cannot reliably determine a POTS phenotype.
Many of the most common symptoms overlap across all three major physiologic patterns. Rapid heart rate, dizziness, fatigue, brain fog, exercise intolerance, nausea, headache, and heat intolerance can occur with neuropathic, hyperadrenergic, hypovolemic, or secondary POTS.
Even findings that appear highly suggestive may have more than one explanation:
Shakiness may reflect sympathetic activation, low blood volume, medication effects, low blood sugar, or another condition.
Purple feet may suggest dependent blood pooling but do not prove small-fiber neuropathy.
Improvement with sodium and fluid may indicate a low-volume contribution, but many patients with POTS experience temporary improvement from increased circulating volume.
Elevated standing norepinephrine may represent primary sympathetic overactivation or compensation for poor blood return.
Symptoms beginning after an infection or concussion suggest a possible secondary cause but do not identify the patient’s physiologic phenotype.
Online questionnaires and symptom lists can help patients organize their observations and prepare for an evaluation. They should not be used to confirm a phenotype, order specialized testing without clinical guidance, or select medications and supplements.
What You Can Do
Patients can contribute valuable information by recording:
Heart rate and blood pressure when lying down and standing
Symptoms that develop while upright
Triggers such as heat, meals, exercise, illness, menstruation, or poor sleep
The duration of symptom flares and recovery
Responses to hydration, sodium, compression, medication, and activity
The timeline between an illness or injury and the onset of symptoms.
Use symptom patterns to guide better questions, not to assign yourself a diagnosis.
Looking Beyond the POTS Diagnosis
At NeuroSport Spine and Concussion Center, the evaluation does not stop after documenting that the heart rate rises with standing. We examine the broader clinical pattern to better understand what may be contributing to the patient’s orthostatic intolerance.
Having evaluated and treated more than 450 patients with POTS and dysautonomia, we recognize that patients who share the same diagnosis may have very different impairments, triggers, associated conditions, and recovery needs.
A NeuroSport Evaluation May Include
A detailed review of symptom onset, health history, prior testing and progression of symptoms
Assessment of possible illness, injury, or other contributing conditions
Supine and standing heart rate and blood pressure measurements
Active Stand or NASA Lean testing
Evaluation of symptom and blood-pressure patterns during orthostatic stress
Assessment of circulation, blood pooling, neurologic function, balance, vision, and exercise tolerance
Review of hydration, nutrition, sleep, medications, and daily activity
Identification of findings that may require laboratory studies, cardiac testing, autonomic testing, or referral to another specialist
The purpose is not to manufacture a tidy label when the findings do not support one. The purpose is to identify the dominant physiologic pattern, determine which factors are modifiable, and build a recovery plan that can be measured and adjusted over time.
You Deserve More Than a Diagnosis Without a Plan
If you have been diagnosed with POTS but still do not understand why you remain symptomatic or what to do next, a more comprehensive evaluation may help clarify the path forward.
Frequently Asked Questions About POTS Phenotypes
How many POTS phenotypes are there?
The strongest evidence supports three major physiologic phenotypes: neuropathic or small-fiber POTS, hyperadrenergic POTS, and hypovolemic or low-volume POTS. These patterns frequently overlap. Secondary POTS is an etiologic category describing POTS that develops in association with another illness, injury, or medical condition.
Can I have more than one POTS phenotype?
Yes. Many patients have a mixed presentation. For example, impaired peripheral vasoconstriction may cause blood pooling and reduced blood return. This may contribute to low circulating volume and trigger a compensatory increase in sympathetic activity.
Is autoimmune POTS a separate phenotype?
Current evidence supports an association between POTS and autoimmune disease in some patients, but autoimmune POTS has not been established as a uniformly defined physiologic phenotype. At NeuroSport, autoimmune-associated POTS is considered within the broader secondary POTS category.
Is POTS after a concussion considered neuropathic POTS?
Not automatically. POTS developing after a concussion or traumatic brain injury is classified as secondary POTS. Neuropathic POTS specifically refers to impaired peripheral autonomic nerve function, often involving small nerve fibers. A patient may have both, but separate evidence is needed to support small-fiber neuropathy.
Does elevated norepinephrine prove hyperadrenergic POTS?
No. An upright norepinephrine level of 600 pg/mL or higher may support a hyperadrenergic pattern, but norepinephrine can also rise as the body compensates for low blood volume, blood pooling, pain, stress, medication effects, or impaired vascular control.
Is low-volume POTS the same as dehydration?
No. Dehydration can temporarily produce or worsen orthostatic tachycardia and should be excluded before diagnosing POTS. Hypovolemic POTS may involve persistent abnormalities in blood volume, sodium retention, fluid regulation, or blood distribution despite adequate fluid intake.
Is there one test that determines my POTS phenotype?
No. Identifying a phenotype requires interpretation of the clinical history, orthostatic heart-rate and blood-pressure patterns, examination findings, laboratory results, associated conditions, and specialized testing when indicated.
Will knowing my phenotype determine my treatment?
Not by itself. The phenotype helps identify which physiologic problems may deserve greater attention, but treatment must also consider the underlying cause, associated conditions, medications, blood pressure, laboratory findings, functional capacity, and response to care.
Can my dominant POTS phenotype change?
Yes. The clinical pattern may change with illness, recovery, medication, physical conditioning, hormonal changes, sleep, heat exposure, nutrition, and treatment. Reassessment is often necessary as recovery progresses.
Can I determine my phenotype using an online checklist?
A checklist can help organize symptoms and generate better questions, but it cannot establish a diagnosis or phenotype. Similar symptoms occur across multiple POTS patterns and other medical conditions.
Continue Learning About POTS and Dysautonomia
What Is POTS?
Learn how POTS is diagnosed and why standing can produce rapid heart rate, dizziness, fatigue, and brain fog.Secondary POTS
Explore how concussion, infection, autoimmune disease, neuropathy, and other conditions may contribute to autonomic dysfunction.Hyperadrenergic POTS
Learn more about excessive sympathetic activation, upright norepinephrine, blood-pressure changes, and anxiety-like physical symptoms.POTS Hydration: Salt, Fluids, and Blood Volume
Understand why hydration involves more than simply drinking additional water.Concussion and Autonomic Dysfunction
Learn how concussion may disrupt the brain-heart connection and contribute to secondary POTS.The Moreau POTS Protocol
Review NeuroSport’s structured, physiology-guided approach to autonomic rehabilitation.POTS Summer Survival Guide
Learn how heat, hydration, travel, and activity can affect orthostatic symptoms.
Medical Disclaimer
This page is provided for general educational purposes only. It is not intended to diagnose POTS, determine an individual patient’s POTS phenotype, replace a comprehensive clinical evaluation, or provide individualized treatment recommendations.
POTS symptoms and physiologic patterns frequently overlap. Similar symptoms may also occur with dehydration, anemia, blood loss, thyroid disease, cardiac rhythm disorders, medication effects, active illness, and other medical conditions. Appropriate evaluation is necessary before symptoms are attributed to POTS.
Do not begin, discontinue, or substantially change medications, sodium intake, fluid intake, compression, supplements, or an exercise program based solely on this information. Individual recommendations must account for blood pressure, cardiac and kidney function, medications, laboratory findings, associated conditions, and response to care.
Seek urgent medical attention for new or severe chest pain, significant difficulty breathing, fainting with injury, sustained or unexplained rapid heart rate, new neurologic symptoms, or other symptoms that may represent a medical emergency.
Scientific References
Sheldon RS, Grubb BP, Olshansky B, et al. 2015 Heart Rhythm Society Expert Consensus Statement on the Diagnosis and Treatment of POTS, Inappropriate Sinus Tachycardia, and Vasovagal Syncope. Heart Rhythm. 2015;12(6):e41-e63.
Raj SR, Guzman JC, Harvey P, et al. Diagnosis and Management of Postural Orthostatic Tachycardia Syndrome. CMAJ. 2022;194(10):E378-E385.
Arnold AC, Ng J, Raj SR. Postural Tachycardia Syndrome: Diagnosis, Physiology, and Prognosis. Autonomic Neuroscience. 2018;215:3-11.
Gibbons CH, Bonyhay I, Benson A, Wang N, Freeman R. Structural and Functional Small-Fiber Abnormalities in the Neuropathic Postural Tachycardia Syndrome. PLoS ONE. 2013;8(12):e84716.
Raj SR, Biaggioni I, Yamhure PC, et al. Renin-Aldosterone Paradox and Perturbed Blood Volume Regulation Underlying Postural Tachycardia Syndrome. Circulation. 2005;111(13):1574-1582.
Okamoto LE, et al. Hyperadrenergic Postural Tachycardia Syndrome: Clinical Biomarkers and Response to Guanfacine. Hypertension. 2024.
Zhang R, et al. Skin Biopsy and Quantitative Sudomotor Axon Reflex Testing in Patients With POTS. Cureus. 2022;14(11):e31059.
Peña C, et al. Autoimmunity in Syndromes of Orthostatic Intolerance. 2024.